Innocoll Pharms Drug Patent Portfolio
Innocoll Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Innocoll Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11746141 | Modified collagen | 09 Jan, 2033 | Active |
| USRE47826 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage | 20 May, 2029 | Active |
Latest Legal Activities on Innocoll Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Innocoll Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 05 Sep, 2023 | US11746141 |
| Recordation of Patent eGrant | 05 Sep, 2023 | US11746141 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Sep, 2023 | US11746141 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Sep, 2023 | US11746141 |
| Mail Patent eGrant Notification | 05 Sep, 2023 | US11746141 |
| Patent eGrant Notification | 05 Sep, 2023 | US11746141 |
|
Email Notification
Critical
| 18 Aug, 2023 | US11746141 |
|
Issue Notification Mailed
Critical
| 16 Aug, 2023 | US11746141 |
|
Application Is Considered Ready for Issue
Critical
| 20 Jul, 2023 | US11746141 |
| Dispatch to FDC | 20 Jul, 2023 | US11746141 |
|
Issue Fee Payment Verified
Critical
| 17 Jul, 2023 | US11746141 |
|
Issue Fee Payment Received
Critical
| 17 Jul, 2023 | US11746141 |
| Miscellaneous Incoming Letter | 14 Jul, 2023 | US11746141 |
|
Electronic Review
Critical
| 25 May, 2023 | US11746141 |
|
Email Notification
Critical
| 25 May, 2023 | US11746141 |
Innocoll Pharms's Family Patents
Innocoll Pharms Drug List
Given below is the complete list of Innocoll Pharms's drugs and the patents protecting them.
1. Xaracoll
Xaracoll is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11746141 | Modified collagen |
09 Jan, 2033
(8 years from now)
| Active |
| USRE47826 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
20 May, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xaracoll's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List